Innate Immunity Stimulation Via TLR9 in Early AD

NCT05606341 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer Dementia

Interventions

DRUG: CpG1018
DRUG: CpG1018
DRUG: CpG1018
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]